Free Trial

Los Angeles Capital Management LLC Cuts Holdings in Exponent, Inc. (NASDAQ:EXPO)

Los Angeles Capital Management LLC reduced its holdings in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 52.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 8,609 shares of the business services provider's stock after selling 9,411 shares during the period. Los Angeles Capital Management LLC's holdings in Exponent were worth $758,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in EXPO. Natixis Advisors L.P. increased its stake in shares of Exponent by 1.3% during the 4th quarter. Natixis Advisors L.P. now owns 35,978 shares of the business services provider's stock worth $3,167,000 after purchasing an additional 463 shares during the last quarter. Heritage Wealth Management LLC acquired a new position in shares of Exponent during the 4th quarter worth about $334,000. Norden Group LLC increased its stake in shares of Exponent by 14.9% during the 4th quarter. Norden Group LLC now owns 3,850 shares of the business services provider's stock worth $339,000 after purchasing an additional 500 shares during the last quarter. Van ECK Associates Corp increased its stake in shares of Exponent by 35.5% during the 4th quarter. Van ECK Associates Corp now owns 17,247 shares of the business services provider's stock worth $1,518,000 after purchasing an additional 4,521 shares during the last quarter. Finally, Capital Investment Counsel Inc acquired a new position in shares of Exponent during the 4th quarter worth about $409,000. 92.37% of the stock is currently owned by institutional investors and hedge funds.


Insider Buying and Selling at Exponent

In other Exponent news, VP Bradley A. James sold 3,528 shares of the business's stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $95.00, for a total value of $335,160.00. Following the completion of the sale, the vice president now owns 2,030 shares of the company's stock, valued at approximately $192,850. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Exponent news, insider Eric Guyer sold 1,650 shares of the business's stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $92.58, for a total value of $152,757.00. Following the completion of the sale, the insider now owns 1,846 shares of the company's stock, valued at approximately $170,902.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Bradley A. James sold 3,528 shares of the company's stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $95.00, for a total transaction of $335,160.00. Following the sale, the vice president now directly owns 2,030 shares of the company's stock, valued at approximately $192,850. The disclosure for this sale can be found here. Insiders sold 5,191 shares of company stock valued at $489,126 in the last quarter. Company insiders own 2.20% of the company's stock.

Exponent Stock Performance

Shares of EXPO stock traded down $0.13 during midday trading on Friday, hitting $94.33. 240,763 shares of the company were exchanged, compared to its average volume of 312,828. The firm has a market capitalization of $4.78 billion, a P/E ratio of 47.64 and a beta of 0.64. The firm's 50 day moving average price is $82.93 and its two-hundred day moving average price is $82.29. Exponent, Inc. has a 52 week low of $64.61 and a 52 week high of $102.72.

Exponent (NASDAQ:EXPO - Get Free Report) last announced its earnings results on Thursday, April 25th. The business services provider reported $0.59 EPS for the quarter, topping the consensus estimate of $0.46 by $0.13. The business had revenue of $137.21 million during the quarter, compared to the consensus estimate of $125.98 million. Exponent had a net margin of 18.72% and a return on equity of 28.13%. Exponent's revenue was up 6.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.56 EPS. Analysts expect that Exponent, Inc. will post 1.92 EPS for the current year.

Exponent Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 21st. Shareholders of record on Friday, June 7th will be issued a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date is Friday, June 7th. Exponent's dividend payout ratio is currently 56.57%.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. StockNews.com upgraded shares of Exponent from a "sell" rating to a "hold" rating in a research note on Monday, March 4th. Truist Financial lifted their target price on shares of Exponent from $95.00 to $100.00 and gave the stock a "buy" rating in a report on Monday, April 29th.

Read Our Latest Research Report on EXPO

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Articles

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Exponent right now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Featured Articles and Offers

Search Headlines: